Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 35.05
+0.65 (1.89%)
Oct 23, 2026, 3:00 PM CST
Autobio Diagnostics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20,028 | 20,240 | 24,967 | 33,123 | 36,261 | 32,280 | |
Market Cap Growth | -10.15% | -18.93% | -24.62% | -8.65% | 12.33% | -50.70% |
Enterprise Value | 16,971 | 19,525 | 24,799 | 33,507 | 35,789 | 31,993 |
Last Close Price | 35.05 | 34.04 | 40.59 | 51.94 | 55.51 | 48.65 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.34 | 18.95 | 20.90 | 27.21 | 31.06 | 33.15 |
Forward PE | 18.51 | 16.00 | 16.30 | 24.79 | 28.63 | 31.67 |
PS Ratio | 4.74 | 4.79 | 5.58 | 7.45 | 8.16 | 8.57 |
PB Ratio | 2.28 | 2.25 | 2.87 | 3.82 | 4.58 | 4.36 |
P/TBV Ratio | 2.41 | 2.36 | 3.00 | 4.04 | 4.89 | 4.69 |
P/FCF Ratio | 31.16 | 27.45 | 38.72 | 58.17 | 58.48 | 81.64 |
P/OCF Ratio | 17.46 | 15.09 | 19.07 | 22.54 | 23.27 | 22.09 |
PEG Ratio | 10.33 | 6.15 | 1.52 | 1.53 | 1.05 | 2.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.02 | 4.62 | 5.55 | 7.54 | 8.06 | 8.49 |
EV/EBITDA Ratio | 11.52 | 12.89 | 15.34 | 20.40 | 23.18 | 23.87 |
EV/EBIT Ratio | 16.59 | 18.39 | 21.52 | 27.78 | 31.78 | 33.53 |
EV/FCF Ratio | 26.40 | 26.48 | 38.46 | 58.84 | 57.71 | 80.91 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.06 | 0.08 | 0.02 | 0.04 |
Debt / EBITDA Ratio | 0.04 | 0.04 | 0.34 | 0.44 | 0.09 | 0.19 |
Debt / FCF Ratio | 0.08 | 0.07 | 0.86 | 1.28 | 0.23 | 0.65 |
Net Debt / Equity Ratio | -0.36 | -0.44 | -0.40 | -0.44 | -0.52 | -0.47 |
Net Debt / EBITDA Ratio | -2.15 | -2.64 | -2.16 | -2.31 | -2.68 | -2.63 |
Net Debt / FCF Ratio | -4.90 | -5.42 | -5.41 | -6.65 | -6.67 | -8.90 |
Asset Turnover | 0.36 | 0.35 | 0.38 | 0.40 | 0.45 | 0.43 |
Inventory Turnover | 1.36 | 1.44 | 1.64 | 2.11 | 2.75 | 2.90 |
Quick Ratio | 1.95 | 2.02 | 2.00 | 2.31 | 2.49 | 3.30 |
Current Ratio | 2.42 | 2.40 | 2.46 | 2.66 | 2.89 | 3.81 |
Return on Equity (ROE) | 11.67% | 12.27% | 13.82% | 14.77% | 15.52% | 14.01% |
Return on Assets (ROA) | 5.46% | 5.49% | 6.15% | 6.85% | 7.14% | 6.87% |
Return on Invested Capital (ROIC) | 13.11% | 18.46% | 21.27% | 25.05% | 27.02% | 24.48% |
Return on Capital Employed (ROCE) | 10.80% | 11.00% | 12.50% | 13.30% | 13.60% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.92% | 5.28% | 4.78% | 3.67% | 3.22% | 3.02% |
FCF Yield | 3.21% | 3.64% | 2.58% | 1.72% | 1.71% | 1.23% |
Dividend Yield | 3.74% | 3.70% | 2.91% | 1.85% | 1.28% | 1.36% |
Payout Ratio | 75.57% | 68.04% | 52.19% | 39.36% | 37.60% | 40.55% |
Buyback Yield / Dilution | -0.73% | 1.02% | 0.47% | 0.68% | 0.48% | -5.10% |
Total Shareholder Return | 3.01% | 4.72% | 3.38% | 2.53% | 1.76% | -3.74% |